Molecular Targeted Therapies in Cancer

A Livestrong Cancer Institutes Podcast Discussion with Professor Kowalski-Muegge

Professor Kowalski-Muegge
was invited to talk about her development and lead of the Livestrong Cancer Institute’s first-ever research molecular tumor board, TOMWAY (Total Molecular Profiles with Actionable Yields). In her leadership role as Associate Director, Cancer Clinical Genomics, Dr. Kowalski-Muegge is leading efforts to educate and inform on molecularly-targeted treatment for cancer. 



Leave a Reply

Your email address will not be published. Required fields are marked *

Social Widgets powered by